TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012
TCL Archive ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent. March 14, 2008